BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11888934)

  • 1. Activation of the Erk mitogen-activated protein kinase pathway stimulates neuroendocrine differentiation in LNCaP cells independently of cell cycle withdrawal and STAT3 phosphorylation.
    Kim J; Adam RM; Freeman MR
    Cancer Res; 2002 Mar; 62(5):1549-54. PubMed ID: 11888934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6- and cyclic AMP-mediated signaling potentiates neuroendocrine differentiation of LNCaP prostate tumor cells.
    Deeble PD; Murphy DJ; Parsons SJ; Cox ME
    Mol Cell Biol; 2001 Dec; 21(24):8471-82. PubMed ID: 11713282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of cholesterol-rich lipid rafts in interleukin-6-induced neuroendocrine differentiation of LNCaP prostate cancer cells.
    Kim J; Adam RM; Solomon KR; Freeman MR
    Endocrinology; 2004 Feb; 145(2):613-9. PubMed ID: 14563701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-6 induces neuroendocrine dedifferentiation and cell proliferation in non-small cell lung cancer cells.
    Chang KT; Tsai CM; Chiou YC; Chiu CH; Jeng KS; Huang CY
    Am J Physiol Lung Cell Mol Physiol; 2005 Sep; 289(3):L446-53. PubMed ID: 15894558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6-induced STAT3 transactivation and Ser727 phosphorylation involves Vav, Rac-1 and the kinase SEK-1/MKK-4 as signal transduction components.
    Schuringa JJ; Jonk LJ; Dokter WH; Vellenga E; Kruijer W
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):89-96. PubMed ID: 10727406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
    Badache A; Hynes NE
    Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGF prevents the neuroendocrine differentiation of LNCaP cells induced by serum deprivation: the modulator role of PI3K/Akt.
    Martín-Orozco RM; Almaraz-Pro C; Rodríguez-Ubreva FJ; Cortés MA; Ropero S; Colomer R; López-Ruiz P; Colás B
    Neoplasia; 2007 Aug; 9(8):614-24. PubMed ID: 17898861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ErbB kinases and NDF signaling in human prostate cancer cells.
    Grasso AW; Wen D; Miller CM; Rhim JS; Pretlow TG; Kung HJ
    Oncogene; 1997 Nov; 15(22):2705-16. PubMed ID: 9400997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive intestinal peptide induces neuroendocrine differentiation in the LNCaP prostate cancer cell line through PKA, ERK, and PI3K.
    Gutiérrez-Cañas I; Juarranz MG; Collado B; Rodríguez-Henche N; Chiloeches A; Prieto JC; Carmena MJ
    Prostate; 2005 Apr; 63(1):44-55. PubMed ID: 15468165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genistein-induced neuroendocrine differentiation of prostate cancer cells.
    Pinski J; Wang Q; Quek ML; Cole A; Cooc J; Danenberg K; Danenberg PV
    Prostate; 2006 Aug; 66(11):1136-43. PubMed ID: 16652383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The functional synergy between IL-12 and IL-2 involves p38 mitogen-activated protein kinase and is associated with the augmentation of STAT serine phosphorylation.
    Gollob JA; Schnipper CP; Murphy EA; Ritz J; Frank DA
    J Immunol; 1999 Apr; 162(8):4472-81. PubMed ID: 10201984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling through PI3K/Akt mediates stretch and PDGF-BB-dependent DNA synthesis in bladder smooth muscle cells.
    Adam RM; Roth JA; Cheng HL; Rice DC; Khoury J; Bauer SB; Peters CA; Freeman MR
    J Urol; 2003 Jun; 169(6):2388-93. PubMed ID: 12771803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells.
    Chen T; Wang LH; Farrar WL
    Cancer Res; 2000 Apr; 60(8):2132-5. PubMed ID: 10786674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of epidermal growth factor receptor induces sequestration of extracellular signal-related kinases and selective attenuation of specific epidermal growth factor-mediated signal transduction pathways.
    Habib AA; Chun SJ; Neel BG; Vartanian T
    Mol Cancer Res; 2003 Jan; 1(3):219-33. PubMed ID: 12556561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade.
    Ogata A; Chauhan D; Teoh G; Treon SP; Urashima M; Schlossman RL; Anderson KC
    J Immunol; 1997 Sep; 159(5):2212-21. PubMed ID: 9278309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta1 transcriptionally activates CD34 and prevents induced differentiation of TF-1 cells in the absence of any cell-cycle effects.
    Marone M; Scambia G; Bonanno G; Rutella S; de Ritis D; Guidi F; Leone G; Pierelli L
    Leukemia; 2002 Jan; 16(1):94-105. PubMed ID: 11840268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor induces hypertrophic responses and Stat5 activation in rat ventricular cardiomyocytes.
    Rebsamen MC; Arrighi JF; Juge-Aubry CE; Vallotton MB; Lang U
    J Mol Cell Cardiol; 2000 Apr; 32(4):599-610. PubMed ID: 10756117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3.
    Edlund S; Bu S; Schuster N; Aspenström P; Heuchel R; Heldin NE; ten Dijke P; Heldin CH; Landström M
    Mol Biol Cell; 2003 Feb; 14(2):529-44. PubMed ID: 12589052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The phosphatidylinositol 3'-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells.
    Lin J; Adam RM; Santiestevan E; Freeman MR
    Cancer Res; 1999 Jun; 59(12):2891-7. PubMed ID: 10383151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.